156 related articles for article (PubMed ID: 479572)
41. Vasoactive intestinal peptide nerves in ocular and orbital structures of the cat.
Uddman R; Alumets J; Ehinger B; Håkanson R; Lorén I; Sundler F
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):878-85. PubMed ID: 6997222
[TBL] [Abstract][Full Text] [Related]
42. Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.
Itoh S; Hirota R; Katsuura G
Jpn J Physiol; 1982; 32(4):553-60. PubMed ID: 6294390
[TBL] [Abstract][Full Text] [Related]
43. Accelerated synthesis de novo of phosphatidylinositols in the rat exocrine pancreas is not necessarily associated with enzymatic hypersecretion. Secretin and vasoactive intestinal peptide (VIP) stimulate amylase output in vitro without favouring this synthesis [proceedings].
Calderon P; Furnelle J; Christophe J
Arch Int Physiol Biochim; 1977 Apr; 85(2):318-9. PubMed ID: 71091
[No Abstract] [Full Text] [Related]
44. The molecular nature of cholecystokinin in the feline pancreas and related nervous structures.
Cantor P; Rehfeld JF
Regul Pept; 1984 Apr; 8(3):199-208. PubMed ID: 6463284
[TBL] [Abstract][Full Text] [Related]
45. Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas.
Uhlemann ER; Robberecht P; Gardner JD
Gastroenterology; 1979 May; 76(5 Pt 1):917-25. PubMed ID: 220130
[TBL] [Abstract][Full Text] [Related]
46. Distribution of [Met5]- and [Leu5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands.
Linnoila RI; Diaugustine RP; Hervonen A; Miller RJ
Neuroscience; 1980; 5(12):2247-59. PubMed ID: 6162130
[No Abstract] [Full Text] [Related]
47. Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body.
Wharton J; Polak JM; Pearse AG; McGregor GP; Bryant MG; Bloom SR; Emson PC; Bisgard GE; Will JA
Nature; 1980 Mar; 284(5753):269-71. PubMed ID: 6153760
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of action of cholecystokinin on intestinal blood flow; interactions with opioid peptides and vasoactive intestinal peptide.
Rozsa Z; Varro V
Neuropeptides; 1985 Mar; 6(1):71-81. PubMed ID: 3990924
[TBL] [Abstract][Full Text] [Related]
49. VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion.
Ahrén B; Alumets J; Ericsson M; Fahrenkrug J; Fahrenkrug L; Håkanson R; Hedner P; Lorén I; Melander A; Rerup C; Sundler F
Nature; 1980 Sep; 287(5780):343-5. PubMed ID: 6252473
[TBL] [Abstract][Full Text] [Related]
50. [Effects of chlorpromazine, beta-endorphin and vasoactive intestinal polypeptide on plasma growth hormone levels in unanesthetized rats (author's transl)].
Wakabayashi I; Miyoshi H; Oomura E; Shizume K
Horumon To Rinsho; 1980; 28(6):633-8. PubMed ID: 7418239
[No Abstract] [Full Text] [Related]
51. Use of immunoblockade to study the involvement of peptidergic afferent nerves in the intestinal vasodilatory response to capsaicin in the dog.
Rózsa Z; Varró A; Jancsó G
Eur J Pharmacol; 1985 Sep; 115(1):59-64. PubMed ID: 2412858
[TBL] [Abstract][Full Text] [Related]
52. Nerve growth factor increases substance P, cholecystokinin and vasoactive intestinal polypeptide immunoreactivities in primary sensory neurones of newborn rats.
Otten U; Lorez HP
Neurosci Lett; 1982 Dec; 34(2):153-8. PubMed ID: 6191253
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of pancreatic secretion by enkephalin and morphine in dogs.
Konturek SJ; Tasler J; Cieszkowski M; Jaworek J; Coy DH; Schally AV
Gastroenterology; 1978 May; 74(5 Pt 1):851-5. PubMed ID: 25222
[TBL] [Abstract][Full Text] [Related]
54. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin.
Guzman S; Chayvialle JA; Banks WA; Rayford PL; Thompson JC
Surgery; 1979 Aug; 86(2):329-36. PubMed ID: 462378
[TBL] [Abstract][Full Text] [Related]
55. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures.
Malarkey WB; O'Dorisio TM; Kennedy M; Cataland S
Life Sci; 1981 Jun; 28(22):2489-95. PubMed ID: 7253836
[No Abstract] [Full Text] [Related]
56. Effects of vasoactive intestinal polypeptide on resistance and capacitance vessels in the nasal mucosa.
Malm L; Sundler F; Uddman R
Acta Otolaryngol; 1980; 90(3-4):304-8. PubMed ID: 7468189
[TBL] [Abstract][Full Text] [Related]
57. The actions of motilin, luteinizing hormone releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral cortical neurons.
Phillis JW; Kirkpatrick JR
Can J Physiol Pharmacol; 1980 Jun; 58(6):612-23. PubMed ID: 6107174
[TBL] [Abstract][Full Text] [Related]
58. Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion.
Konturek SJ; Zabielski R; Konturek JW; Czarnecki J
Eur J Pharmacol; 2003 Nov; 481(1):1-14. PubMed ID: 14637169
[TBL] [Abstract][Full Text] [Related]
59. The peptidergic neural control of the feline pylorus.
Edin R; Lundberg J; Dahlström A; Hökfelt T; Terenius L; Ahlman H
Chir Forum Exp Klin Forsch; 1980; ():233-7. PubMed ID: 6156058
[TBL] [Abstract][Full Text] [Related]
60. Relations between neuropeptides and gut hormones.
Dockray GJ; Gregory RA
Proc R Soc Lond B Biol Sci; 1980 Oct; 210(1178):151-64. PubMed ID: 6107927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
